NCT03552510

Brief Summary

Mother's milk does not come in contact with the oropharyngeal pouch of preterm infants during gavage feeding. We hypothesized that stimulation of the oropharyngeal pouch using small amount of the mother's milk 5 minutes before initiation of regular gavage feeding will increase the level of GIT hormones.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jun 2016

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2016

Completed
2 years until next milestone

First Submitted

Initial submission to the registry

May 29, 2018

Completed
14 days until next milestone

First Posted

Study publicly available on registry

June 12, 2018

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2018

Completed
Last Updated

March 15, 2021

Status Verified

March 1, 2021

Enrollment Period

2.6 years

First QC Date

May 29, 2018

Last Update Submit

March 12, 2021

Conditions

Outcome Measures

Primary Outcomes (4)

  • Motilin hormone

    Plasma Motilin hormone level

    24 hours

  • Gastrin hormone

    Plasma Gastrin hormone level

    24 hours

  • Secretin hormone

    Plasma Secretin hormone level

    24 hours

  • Cholecystokinin

    Plasma Cholecystokinin hormone level

    24 hours

Secondary Outcomes (2)

  • Feeding residual

    24 hours

  • Holding feeds

    24 hours

Study Arms (2)

Initial OPAMM

ACTIVE COMPARATOR

At the start of the study, infants will receive mother's milk (to the maximum of 0.2 ml) to the oro-pharyngeal pouch, tongue and cheeks every 3 hours (5 minutes before time of feeding), and the remaining amount will be given by regular gavage feeding for 24 hours. Then, infants will receive regular gavage feeding only for the next 24 hours.

Procedure: Oro-pharyngeal Administration of Mother's Milk

Initial Gavage

ACTIVE COMPARATOR

At the start of the study, infants will receive regular gavage feeding only for 24 hours. Then, infants will receive mother's milk (to the maximum of 0.2 ml ) by dropper to the oro-pharyngeal pouch, tongue and cheeks every 3 hours (5 minutes before time of feeding), and the remaining amount will be given by regular gavage feeding for the next 24 hours.

Procedure: Oro-pharyngeal Administration of Mother's Milk

Interventions

Infants will receive mother's milk (to the maximum of 0.2 ml ) by dropper to the oro-pharyngeal pouch, tongue and cheeks every 3 hours (5 minutes before time of feeding)

Initial GavageInitial OPAMM

Eligibility Criteria

Age1 Day - 60 Days
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Preterm infants delivered at less than 32 weeks gestation and less than 1500 grams birth weight will be included in the study

You may not qualify if:

  • Preterm infants \> 32 weeks gestation unable to be fed on own mother's colostrum or milk.
  • Preterm infants with major congenital anomalies or chromosomal abnormalities.
  • Preterm infants delivered to mothers with confirmed chorioamnionitis.
  • Preterm infants with confirmed early onset sepsis.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Mansoura University Children Hospital

Al Mansurah, El Dakahlya, 35111, Egypt

Location

MeSH Terms

Conditions

Premature Birth

Condition Hierarchy (Ancestors)

Obstetric Labor, PrematureObstetric Labor ComplicationsPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Laboratory assessment of GIT hormonal level will be masked
Purpose
SUPPORTIVE CARE
Intervention Model
CROSSOVER
Model Details: Oropharyngeal Administration of mother's milk (OPAMM)
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of Pediatrics

Study Record Dates

First Submitted

May 29, 2018

First Posted

June 12, 2018

Study Start

June 1, 2016

Primary Completion

December 30, 2018

Study Completion

December 30, 2018

Last Updated

March 15, 2021

Record last verified: 2021-03

Locations